April 2026- Cambridge Health Group (“CHG”), the GCC’s leading post-acute care provider and a subsidiary of Amanat Holdings PJSC (“Amanat”), announced the inauguration of its fully refurbished and expanded Cambridge Hospital Jeddah, now a 200-bed specialist facility operating at full capacity.
This expansion reinforces Cambridge Health Group’s position as the largest post-acute care provider in the GCC with over 700 beds across its network and reflects its continued commitment to expanding high-quality healthcare services across the Kingdom of Saudi Arabia, United Arab Emirates and the wider region.
The Jeddah hospital has been comprehensively upgraded and expanded from 130 to 200 beds, introducing enhanced patient rooms, advanced clinical infrastructure and a significantly expanded rehabilitation offering, including dedicated gym facilities delivering a patient centric environment. The development builds on Cambridge’s recent expansion trajectory in the Kingdom, including the launch of a 150-bed long-term care facility in Khobar in 2024 and a 70-bed rehabilitation hospital in Dhahran in 2019.
Click here to join our WhatsApp channel here
Dr. Ali Saeed bin Harmal Aldhaheri, Chairman of Cambridge Health Group, said:
“Saudi Arabia is a core growth market for Cambridge Health Group. This expansion reflects our long-term commitment to the Kingdom and our confidence in the continued development of its healthcare sector. With over 700 beds across the GCC and a clear pipeline for further expansion, we are proud to be building the region’s leading post-acute care provider and delivering world-class clinical outcomes at scale.”
Also read: FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B
Dr. Mohammed Halawani, KSA Chief Executive Officer of Cambridge Health Group, said:
“The Jeddah hospital is operating at full capacity, reflecting both the quality of care we provide and the significant demand for specialised post-acute and rehabilitation services in the Kingdom. This expansion, alongside our ongoing development pipeline, positions us to further enhance patient access and align with the Kingdom’s healthcare transformation agenda under Vision 2030.”
